Dan Brennan
Stock Analyst at TD Cowen
(3.74)
# 575
Out of 5,182 analysts
126
Total ratings
46.88%
Success rate
9.65%
Average return
Main Sectors:
Stocks Rated by Dan Brennan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| A Agilent Technologies | Maintains: Buy | $170 → $157 | $115.62 | +35.79% | 14 | Feb 26, 2026 | |
| XGN Exagen | Maintains: Buy | $13 → $10 | $2.74 | +264.96% | 1 | Feb 24, 2026 | |
| GH Guardant Health | Maintains: Buy | $130 → $135 | $88.50 | +52.54% | 4 | Feb 20, 2026 | |
| BRKR Bruker | Maintains: Hold | $53 → $43 | $36.53 | +17.71% | 4 | Feb 13, 2026 | |
| TXG 10x Genomics | Maintains: Hold | $18 → $19 | $22.28 | -14.72% | 6 | Feb 13, 2026 | |
| RVTY Revvity | Maintains: Buy | $120 → $124 | $86.80 | +42.86% | 4 | Feb 3, 2026 | |
| TMO Thermo Fisher Scientific | Maintains: Buy | $696 → $683 | $468.04 | +45.93% | 15 | Jan 30, 2026 | |
| ILMN Illumina | Maintains: Hold | $115 → $140 | $128.52 | +8.93% | 14 | Jan 7, 2026 | |
| DHR Danaher | Maintains: Buy | $260 → $270 | $180.62 | +49.49% | 7 | Jan 7, 2026 | |
| AVTR Avantor | Maintains: Hold | $14 → $12 | $7.97 | +50.56% | 4 | Jan 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $7 | $2.04 | +243.14% | 2 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $345 → $390 | $299.79 | +30.09% | 4 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $8 → $9 | $4.83 | +86.34% | 2 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $12 | $8.61 | +39.37% | 7 | Sep 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $15 | $14.21 | +5.56% | 1 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $32 | $19.93 | +60.56% | 1 | Jul 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $135 → $110 | $66.17 | +66.24% | 4 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $8 → $2.5 | $3.68 | -32.07% | 4 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $74 | $52.68 | +40.47% | 2 | Feb 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $155 → $175 | $204.39 | -14.38% | 4 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $240 → $250 | $171.23 | +46.00% | 5 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $48 → $51 | $47.10 | +8.28% | 2 | Jul 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $56 | $10.13 | +453.09% | 1 | May 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $545 → $546 | $146.94 | +271.58% | 4 | Dec 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $13 → $15 | $1.59 | +843.40% | 1 | Mar 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $207 → $232 | $103.21 | +124.78% | 6 | Mar 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | $770 → $880 | $1,274.70 | -30.96% | 3 | Oct 7, 2020 |
Agilent Technologies
Feb 26, 2026
Maintains: Buy
Price Target: $170 → $157
Current: $115.62
Upside: +35.79%
Exagen
Feb 24, 2026
Maintains: Buy
Price Target: $13 → $10
Current: $2.74
Upside: +264.96%
Guardant Health
Feb 20, 2026
Maintains: Buy
Price Target: $130 → $135
Current: $88.50
Upside: +52.54%
Bruker
Feb 13, 2026
Maintains: Hold
Price Target: $53 → $43
Current: $36.53
Upside: +17.71%
10x Genomics
Feb 13, 2026
Maintains: Hold
Price Target: $18 → $19
Current: $22.28
Upside: -14.72%
Revvity
Feb 3, 2026
Maintains: Buy
Price Target: $120 → $124
Current: $86.80
Upside: +42.86%
Thermo Fisher Scientific
Jan 30, 2026
Maintains: Buy
Price Target: $696 → $683
Current: $468.04
Upside: +45.93%
Illumina
Jan 7, 2026
Maintains: Hold
Price Target: $115 → $140
Current: $128.52
Upside: +8.93%
Danaher
Jan 7, 2026
Maintains: Buy
Price Target: $260 → $270
Current: $180.62
Upside: +49.49%
Avantor
Jan 7, 2026
Maintains: Hold
Price Target: $14 → $12
Current: $7.97
Upside: +50.56%
Nov 13, 2025
Maintains: Buy
Price Target: $5 → $7
Current: $2.04
Upside: +243.14%
Nov 5, 2025
Maintains: Hold
Price Target: $345 → $390
Current: $299.79
Upside: +30.09%
Nov 4, 2025
Maintains: Hold
Price Target: $8 → $9
Current: $4.83
Upside: +86.34%
Sep 12, 2025
Maintains: Buy
Price Target: $10 → $12
Current: $8.61
Upside: +39.37%
Aug 6, 2025
Maintains: Buy
Price Target: $13 → $15
Current: $14.21
Upside: +5.56%
Jul 14, 2025
Initiates: Buy
Price Target: $32
Current: $19.93
Upside: +60.56%
May 1, 2025
Maintains: Buy
Price Target: $135 → $110
Current: $66.17
Upside: +66.24%
Mar 21, 2025
Maintains: Neutral
Price Target: $8 → $2.5
Current: $3.68
Upside: -32.07%
Feb 5, 2025
Reinstates: Buy
Price Target: $74
Current: $52.68
Upside: +40.47%
Nov 13, 2024
Maintains: Buy
Price Target: $155 → $175
Current: $204.39
Upside: -14.38%
Nov 7, 2024
Maintains: Buy
Price Target: $240 → $250
Current: $171.23
Upside: +46.00%
Jul 23, 2024
Maintains: Buy
Price Target: $48 → $51
Current: $47.10
Upside: +8.28%
May 13, 2024
Initiates: Buy
Price Target: $56
Current: $10.13
Upside: +453.09%
Dec 8, 2023
Maintains: Outperform
Price Target: $545 → $546
Current: $146.94
Upside: +271.58%
Mar 31, 2023
Upgrades: Outperform
Price Target: $13 → $15
Current: $1.59
Upside: +843.40%
Mar 1, 2021
Upgrades: Buy
Price Target: $207 → $232
Current: $103.21
Upside: +124.78%
Oct 7, 2020
Downgrades: Sell
Price Target: $770 → $880
Current: $1,274.70
Upside: -30.96%